'Breast cancer is coming within reach of immunotherapy’


Breast cancer has not hitherto been at the forefront of immunotherapy treatment. At the 17th Bossche Mamma Congress, Dr. Marleen Kok (of The Netherlands Cancer Institute) explains why, and how immunotherapy is gradually gaining traction in the treatment of breast cancer.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.